William Blair

Selected news for William Blair, representing 1% of data collected since 10/2017. Recent stories appear in dispatchtribunal.com and marketbeat.com. This capital firm shares healthcare news with CRISPR, Medical Research, Amedisys, Abbott Laboratories, Henry Schein and hundreds of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
1/14/2021 Lemonade Announces Upsizing and Pricing of Public Offering of Common Stock Business Wire ... Sachs & Co. LLC, Morgan Stanley & Co. LLC, Allen & Company LLC and Barclays Capital Inc. are serving as the joint active bookrunners for the Offering. JMP Securities LLC, Oppenheimer & Co. Inc., Piper Sandler & Co. and William Blair & Company, L.L.C. are acting as co-managers for the Offering.A registration statement relating to the Offering was declared effective by the Securities and Exchange Commission on January 13, 2021 (the “Registration Statement” ...
1/14/2021 FY2020 EPS Estimates for AMN Healthcare Services, Inc. (NYSE:AMN) Increased by Analyst zolmax.com FY2020 EPS Estimates for AMN Healthcare Services, Inc. (NYSE:AMN) Increased by Analyst Posted by Alphonse Anthony on Jan 14th, 2021 TweetAMN Healthcare Services, Inc. (NYSE:AMN) – Research analysts at William Blair lifted their FY2020 earnings per share (EPS) estimates for AMN Healthcare Services in a research report issued on Monday, January 11th. William Blair analyst T. Mulrooney now forecasts that the company will earn $3.25 per share ...
1/10/2021 Piper Sandler Increases Change Healthcare CHNG) Price Target to $25.75 Ticker Report ... research note on Monday, September 14th. Berenberg Bank started coverage on Change Healthcare in a research note on Tuesday, December 8th. They issued a buy rating and a $23.00 price target on the stock. William Blair lowered Change Healthcare from an outperform rating to a market perform rating in a research note on Wednesday. BidaskClub downgraded Change Healthcare from a strong-buy rating to a buy rating in a report ...
1/10/2021 William Blair Lowers Change Healthcare CHNG) to Market Perform Ticker Report William Blair cut shares of Change Healthcare (NASDAQ:CHNG) from an outperform rating to a market perform rating in a report issued on Wednesday morning, The Fly reports.Several other equities analysts also recently issued reports on CHNG. Citigroup boosted their price target on shares of Change Healthcare from $16.00 to $18.00 and gave the company a buy rating in a report on Monday, September 14th. Berenberg Bank initiated coverage ...
1/10/2021 Change Healthcare (NASDAQ:CHNG) Downgraded by Guggenheim to “Neutral” Mayfield Recorder ... recently commented on the company. Deutsche Bank Aktiengesellschaft upped their price target on Change Healthcare from $16.00 to $18.00 and gave the company a buy rating in a research report on Monday, November 9th. William Blair cut Change Healthcare from an outperform rating to a market perform rating in a research report on Wednesday. Citigroup boosted their price objective on Change Healthcare from $16.00 to $18.00 and gave the company ...
1/10/2021 Cowen Lowers Change Healthcare CHNG) to Market Perform Ticker Report ... in a report on Monday, September 14th. Berenberg Bank started coverage on Change Healthcare in a report on Tuesday, December 8th. They set a buy rating and a $23.00 price target for the company. William Blair cut Change Healthcare from an outperform rating to a market perform rating in a report on Wednesday. Credit Suisse Group cut Change Healthcare from an outperform rating to a neutral rating and set a ...
1/9/2021 Guardant Health (NASDAQ:GH) Shares Up 6.8% Mayfield Recorder ... recently commented on GH shares. Morgan Stanley boosted their price target on Guardant Health from $110.00 to $130.00 and gave the stock an “overweight” rating in a research report on Monday, November 9th. William Blair restated an “outperform” rating on shares of Guardant Health in a research note on Thursday, November 12th. SVB Leerink increased their price target on Guardant Health from $130.00 to $150.00 and gave the ...
1/8/2021 Amgen (NASDAQ:AMGN) Rating Reiterated by Royal Bank of Canada Daily Political ... a sell rating in a report on Friday, January 1st. The Goldman Sachs Group lowered shares of Amgen from a conviction-buy rating to a buy rating in a report on Tuesday, December 15th. William Blair reaffirmed a hold rating on shares of Amgen in a report on Wednesday, September 23rd. UBS Group initiated coverage on shares of Amgen in a report on Wednesday, October 28th. They issued a neutral ...
1/8/2021 William Blair Brokers Lift Earnings Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Ticker Report DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Research analysts at William Blair raised their Q2 2021 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a report issued on Tuesday, January 5th. William Blair analyst J. Kreger now expects that the medical instruments supplier will earn $0.54 per share for the quarter, up from their previous forecast of $0.53. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 ...
1/8/2021 Change Healthcare (NASDAQ:CHNG) Rating Lowered to Neutral at Guggenheim Ticker Report ... other analysts have also issued reports on the stock. Raymond James lowered shares of Change Healthcare from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday. William Blair cut Change Healthcare from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Robert W. Baird cut Change Healthcare from an “outperform” rating to a “neutral ...
1/8/2021 Change Healthcare (NASDAQ:CHNG) Lowered to “Hold” at Deutsche Bank Aktiengesellschaft Ticker Report ... in a research note on Wednesday. Citigroup lifted their price objective on Change Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Monday, September 14th. William Blair cut Change Healthcare from an “outperform” rating to a “market perform” rating in a research note on Wednesday. CSFB lifted their price objective on Change Healthcare from $16.00 to $19.00 and gave ...
1/7/2021 Change Healthcare (NASDAQ:CHNG) Downgraded to Neutral at Credit Suisse Group slatersentinel.com ... Suisse Group from an “outperform” rating to a “neutral” rating in a research report issued on Thursday, The Fly reports.A number of other equities analysts have also commented on the company. William Blair lowered Change Healthcare from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Robert W. Baird downgraded Change Healthcare from an “outperform” rating to a “neutral ...
1/7/2021 Analysts Offer Insights on Healthcare Companies: Aeglea Biotherapeutics (AGLE) and Logicbio Therapeutics (LOGC) markets.co Analysts Offer Insights on Healthcare Companies: Aeglea Biotherapeutics (AGLE) and Logicbio Therapeutics (LOGC) Catie Powers - January 7, 2021, 10:45 AM EDT SHARE ON:There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aeglea Biotherapeutics ( AGLE ) and Logicbio Therapeutics ( LOGC ) with bullish sentiments.Aeglea Biotherapeutics (AGLE)LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Aeglea Biotherapeutics yesterday and set ...
1/7/2021 Change Healthcare (NASDAQ:CHNG) Downgraded by Raymond James to Market Perform slatersentinel.com ... in a report on Tuesday, November 24th. Piper Sandler increased their target price on shares of Change Healthcare from $23.00 to $25.75 and gave the stock an overweight rating in a report on Wednesday. William Blair cut shares of Change Healthcare from an outperform rating to a market perform rating in a report on Wednesday. Smith Barney Citigroup increased their target price on shares of Change Healthcare from $19.00 to ...
1/7/2021 DermTech Announces Pricing of Public Offering of Common Stock Business Wire ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book-running managers for the offering. BTIG, Craig-Hallum and Oppenheimer & Co. are acting as lead managers for the offering, and Lake Street Capital Markets is acting as co-manager ...
1/7/2021 DermTech Announces Pricing of Public Offering of Common Stock stocksnewsfeed.com ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book -running managers for the offering. BTIG, Craig-Hallum and Oppenheimer & Co. are acting as lead managers for the offering, and Lake Street Capital Markets is acting as co-manager ...
1/7/2021 malvern-online.com ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book-running managers for the offering. BTIG, Craig-Hallum and Oppenheimer & Co. are acting as lead managers for the offering, and Lake Street Capital Markets is acting as co-manager ...
1/7/2021 DermTech Announces Pricing of Public Offering of Common Stock Business Wire ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book-running managers for the offering. BTIG, Craig-Hallum and Oppenheimer & Co. are acting as lead managers for the offering, and Lake Street Capital Markets is acting as co-manager ...
1/7/2021 DermTech Announces Pricing of Public Offering of Common Stock financialbuzz.com ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book-running managers for the offering. BTIG, Craig-Hallum and Oppenheimer & Co. are acting as lead managers for the offering, and Lake Street Capital Markets is acting as co-manager ...
1/7/2021 DermTech Announces Proposed Public Offering of Common Stock financialbuzz.com ... the net proceeds from the offering to fund further commercialization of its clinical commercial tests, accelerate pipeline development and for general corporate purposes, including working capital and other general and administrative purposes.Cowen and William Blair are acting as joint book-running managers for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be ...